1. CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
2. Liu X.et al. (2015). CD47 blockade triggers T cell‐mediated destruction of immunogenic tumors.Nat. Med.21:1209–1215. doi:10.1038/nm.3931.http://www.nature.com/nm/journal/vaop/ncurrent/abs/nm.3931.html#supplementary-information.
3. CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
4. Harnessing the power of the immune system in non‐Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond;Ansell S.M.;Hematology Am. Soc. Hematol. Educ. Program,2017